Literature DB >> 21194370

The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.

Thomas Steinkellner1, Michael Freissmuth, Harald H Sitte, Therese Montgomery.   

Abstract

Amphetamine ('Speed'), methamphetamine ('Ice') and its congener 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy') are illicit drugs abused worldwide for their euphoric and stimulant effects. Despite compelling evidence for chronic MDMA neurotoxicity in animal models, the physiological consequences of such toxicity in humans remain unclear. In addition, distinct differences in the metabolism and pharmacokinetics of MDMA between species and different strains of animals prevent the rationalisation of realistic human dose paradigms in animal studies. Here, we attempt to review amphetamine toxicity and in particular MDMA toxicity in the pathogenesis of exemplary human pathologies, independently of confounding environmental factors such as poly-drug use and drug purity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21194370      PMCID: PMC4497800          DOI: 10.1515/BC.2011.016

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  175 in total

1.  3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.

Authors:  B Esteban; E O'Shea; J Camarero; V Sanchez; A R Green; M I Colado
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

Review 2.  The norepinephrine transporter in physiology and disease.

Authors:  H Bönisch; M Brüss
Journal:  Handb Exp Pharmacol       Date:  2006

Review 3.  Dopamine receptors and transporters in Parkinson's disease and schizophrenia.

Authors:  P Seeman; H B Niznik
Journal:  FASEB J       Date:  1990-07       Impact factor: 5.191

4.  Interaction of amphetamines and related compounds at the vesicular monoamine transporter.

Authors:  John S Partilla; Allison G Dempsey; Ameet S Nagpal; Bruce E Blough; Michael H Baumann; Richard B Rothman
Journal:  J Pharmacol Exp Ther       Date:  2006-07-11       Impact factor: 4.030

5.  Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Authors:  Jacob U Fog; Habibeh Khoshbouei; Marion Holy; William A Owens; Christian Bjerggaard Vaegter; Namita Sen; Yelyzaveta Nikandrova; Erica Bowton; Douglas G McMahon; Roger J Colbran; Lynette C Daws; Harald H Sitte; Jonathan A Javitch; Aurelio Galli; Ulrik Gether
Journal:  Neuron       Date:  2006-08-17       Impact factor: 17.173

Review 6.  Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research.

Authors:  H V Curran
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

Review 7.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.

Authors:  Linda Chang; Daniel Alicata; Thomas Ernst; Nora Volkow
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

8.  Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA.

Authors:  Larry C Schmued
Journal:  Brain Res       Date:  2003-06-06       Impact factor: 3.252

9.  MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).

Authors:  E T Leonardi; E C Azmitia
Journal:  Neuropsychopharmacology       Date:  1994-07       Impact factor: 7.853

Review 10.  Amphetamine psychosis: a model for studying the onset and course of psychosis.

Authors:  Daniel F Hermens; Dan I Lubman; Philip B Ward; Sharon L Naismith; Ian B Hickie
Journal:  Med J Aust       Date:  2009-02-16       Impact factor: 7.738

View more
  24 in total

1.  [Researcher of the month].

Authors:  Thomas Steinkellner
Journal:  Wien Klin Wochenschr       Date:  2015-05       Impact factor: 1.704

Review 2.  Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

Authors:  Lee E Dunlap; Anne M Andrews; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-07-12       Impact factor: 4.418

3.  Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine.

Authors:  Angelica M Morales; Buyean Lee; Gerhard Hellemann; Joseph O'Neill; Edythe D London
Journal:  Drug Alcohol Depend       Date:  2012-03-22       Impact factor: 4.492

Review 4.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

Review 5.  Contributions of serotonin in addiction vulnerability.

Authors:  L G Kirby; F D Zeeb; C A Winstanley
Journal:  Neuropharmacology       Date:  2011-04-03       Impact factor: 5.250

Review 6.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

7.  Sex differences in MDMA-induced toxicity in Sprague-Dawley rats.

Authors:  Sara Soleimani Asl; Mehdi Mehdizadeh; Soudabeh Hamedi Shahraki; Tayebeh Artimani; Mohammad Taghi Joghataei
Journal:  Funct Neurol       Date:  2015 Apr-Jun

8.  Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters.

Authors:  Walter Sandtner; Thomas Stockner; Peter S Hasenhuetl; John S Partilla; Amir Seddik; Yuan-Wei Zhang; Jianjing Cao; Marion Holy; Thomas Steinkellner; Gary Rudnick; Michael H Baumann; Gerhard F Ecker; Amy Hauck Newman; Harald H Sitte
Journal:  Mol Pharmacol       Date:  2015-10-30       Impact factor: 4.436

9.  Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users.

Authors:  Oliver G Bosch; Michael Wagner; Frank Jessen; Kai-Uwe Kühn; Alexius Joe; Erich Seifritz; Wolfgang Maier; Hans-Jürgen Biersack; Boris B Quednow
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

Review 10.  A practical guide to the therapy of narcolepsy and hypersomnia syndromes.

Authors:  Emmanuel J M Mignot
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.